Serial BST values, in addition to KIT p.D816V VAFs, measured in SM patients after a period of TKI treatment, may help guide when to repeat a BM biopsy to determine whether the SM neoplasm is in pathological remission. This evidence concerns the gene KIT and systemic mastocytosis.